Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.

@article{Kioka2007PredictionOS,
  title={Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.},
  author={Hidetaka Kioka and Takahisa Yamada and Takanao Mine and Takashi Morita and Yasumasa Tsukamoto and Shunsuke Tamaki and Masaharu Masuda and Keiji Okuda and Masatsugu Hori and Masatake Fukunami},
  journal={Heart},
  year={2007},
  volume={93 10},
  pages={1213-8}
}
OBJECTIVE To evaluate the usefulness of cardiac iodine-123 (123I) metaiodobenzylguanidine (MIBG) imaging as a predictor of sudden death in patients with chronic heart failure (CHF). DESIGN AND SETTING Prospective cohort study in a tertiary referral centre. PATIENTS 97 outpatients with CHF with a radionuclide left ventricular ejection fraction <40% (mean… CONTINUE READING